Short answer
Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Former CEO Martin Bonick’s separation reclassified as termination for Cause after Board review.
Ardent Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Former CEO Martin Bonick’s separation reclassified as termination for Cause after Board review
- Board cited undisclosed third-party compensation, raising governance and executive oversight concerns
- Approximately $4.5 million unpaid cash severance discontinued
- Outstanding unvested performance-based restricted stock units cancelled or forfeited
- Company reserved rights to pursue additional remedies; prior financial statements unaffected
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ardent Health, Inc. 8-K filings
Get the next ARDT 8-K as it lands
Follow ARDT for push alerts, or ask the research agent what this filing means.